☰

Yousuke T. Horikawa, Ph.D. - Publications

Affiliations: 
Biomedical Sciences University of California, San Diego, La Jolla, CA 
Area:
Pharmacology
Tree Info Grants Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Okada S, Raja SA, Okerblom J, Boddu A, Horikawa Y, Ray S, Okada H, Kawamura I, Murofushi Y, Murray F, Patel HH. Deletion of caveolin scaffolding domain alters cancer cell migration. Cell Cycle (Georgetown, Tex.). 1-13. PMID 31116089 DOI: 10.1080/15384101.2019.1618118  0.528
2016 Schilling JM, Horikawa YT, Zemljic-Harpf AE, Vincent KP, Tyan L, Yu JK, McCulloch AD, Balijepalli RC, Patel HH, Roth DM. Electrophysiology and metabolism of caveolin-3-overexpressing mice. Basic Research in Cardiology. 111: 28. PMID 27023865 DOI: 10.1007/S00395-016-0542-9  0.64
2016 Sebe M, Tsutsumi R, Yamaguchi S, Horikawa YT, Harada N, Oyama T, Kakuta N, Tanaka K, Tsutsumi YM, Nakaya Y, Sakaue H. The synergystic effects of omega-3 fatty acids against 5-fluorouracil-induced mucosal impairment in mice Bmc Nutrition. 2. DOI: 10.1186/S40795-016-0057-7  0.345
2014 Tsutsumi YM, Tsutsumi R, Horikawa YT, Sakai Y, Hamaguchi E, Kitahata H, Kasai A, Kambe N, Tanaka K. Geranylgeranylacetone and volatile anesthetic-induced cardiac protection synergism is dependent on caveolae and caveolin-3. Journal of Anesthesia. 28: 733-9. PMID 24633659 DOI: 10.1007/S00540-014-1816-8  0.516
2014 Tsutsumi YM, Tsutsumi R, Horikawa YT, Sakai Y, Hamaguchi E, Ishikawa Y, Yokoyama U, Kasai A, Kambe N, Tanaka K. Geranylgeranylacetone protects the heart via caveolae and caveolin-3. Life Sciences. 101: 43-8. PMID 24582814 DOI: 10.1016/J.Lfs.2014.02.019  0.483
2014 Horikawa YT, Tsutsumi YM, Patel HH, Roth DM. Signaling epicenters: the role of caveolae and caveolins in volatile anesthetic induced cardiac protection. Current Pharmaceutical Design. 20: 5681-9. PMID 24502576 DOI: 10.2174/1381612820666140204111236  0.611
2011 Tsutsumi YM, Tomiyama Y, Horikawa YT, Sakai Y, Ohshita N, Tanaka K, Oshita S. General anesthesia for electroconvulsive therapy with Brugada electrocardiograph pattern. The Journal of Medical Investigation : Jmi. 58: 273-6. PMID 21921431 DOI: 10.2152/Jmi.58.273  0.314
2011 Kawaraguchi Y, Horikawa YT, Murphy AN, Murray F, Miyanohara A, Ali SS, Head BP, Patel PM, Roth DM, Patel HH. Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins. Anesthesiology. 115: 499-508. PMID 21862885 DOI: 10.1097/Aln.0B013E3182276D42  0.637
2011 Horikawa YT, Panneerselvam M, Kawaraguchi Y, Tsutsumi YM, Ali SS, Balijepalli RC, Murray F, Head BP, Niesman IR, Rieg T, Vallon V, Insel PA, Patel HH, Roth DM. Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling. Journal of the American College of Cardiology. 57: 2273-83. PMID 21616289 DOI: 10.1016/J.Jacc.2010.12.032  0.723
2010 Panneerselvam M, Tsutsumi YM, Bonds JA, Horikawa YT, Saldana M, Dalton ND, Head BP, Patel PM, Roth DM, Patel HH. Dark chocolate receptors: epicatechin-induced cardiac protection is dependent on delta-opioid receptor stimulation. American Journal of Physiology. Heart and Circulatory Physiology. 299: H1604-9. PMID 20833967 DOI: 10.1152/Ajpheart.00073.2010  0.682
2010 Tsutsumi YM, Kawaraguchi Y, Horikawa YT, Niesman IR, Kidd MW, Chin-Lee B, Head BP, Patel PM, Roth DM, Patel HH. Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection. Anesthesiology. 112: 1136-45. PMID 20418694 DOI: 10.1097/Aln.0B013E3181D3D624  0.703
2008 Tsutsumi YM, Horikawa YT, Jennings MM, Kidd MW, Niesman IR, Yokoyama U, Head BP, Hagiwara Y, Ishikawa Y, Miyanohara A, Patel PM, Insel PA, Patel HH, Roth DM. Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning Circulation. 118: 1979-1988. PMID 18936328 DOI: 10.1161/Circulationaha.108.788331  0.749
2008 Horikawa YT, Patel HH, Tsutsumi YM, Jennings MM, Kidd MW, Hagiwara Y, Ishikawa Y, Insel PA, Roth DM. Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury Journal of Molecular and Cellular Cardiology. 44: 123-130. PMID 18054955 DOI: 10.1016/J.Yjmcc.2007.10.003  0.714
2007 Tsutsumi YM, Yokoyama T, Horikawa Y, Roth DM, Patel HH. Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sciences. 81: 1223-7. PMID 17915258 DOI: 10.1016/J.Lfs.2007.08.031  0.649
2007 Patel HH, Tsutsumi YM, Head BP, Niesman IR, Jennings M, Horikawa Y, Huang D, Moreno AL, Patel PM, Insel PA, Roth DM. Mechanisms of cardiac protection from ischemia/reperfusion injury: A role for caveolae and caveolin-1 Faseb Journal. 21: 1565-1574. PMID 17272740 DOI: 10.1096/Fj.06-7719Com  0.748
Show low-probability matches.